Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo

Journal of Experimental Medicine

Volumn 204, Issue 13, 2007, Pages 3113-3118

  Nieswandt, Bernhard ^a,b   Moser, Markus ^c   Pleines, Irina ^a   Varga Szabo, David ^a   Monkley, Sue ^d   Critchley, David ^d   Fässler, Reinhard ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; TALIN; TALIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY THROMBOSIS; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; HEMOSTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOGENESIS;

EID: 37549029679     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20071827     Document Type: Article

References (30)

1. Ruggeri, Z.M. 2002. Platelets in atherothrombosis. Nat. Med. 8:1227-1234.
2. Nieswandt, B., and S.P. Watson. 2003. Platelet-collagen interaction: is GPVI the central receptor? Blood. 102:449-461.
3. Shattil, S.J., H. Kashiwagi, and N. Pampori. 1998. Integrin signaling: the platelet paradigm. Blood. 91:2645-2657.
4. Hynes, R.O. 2002. Integrins: bidirectional, allosteric signaling machines. Cell. 110:673-687.
5. Martin-Bermudo, M.D., O.M. Dunin-Borkowski, and N.H. Brown. 1998. Modulation of integrin activity is vital for morphogenesis. J. Cell Biol. 141:1073-1081.
6. McDowall, A., D. Inwald, B. Leitinger, A. Jones, R. Liesner, N. Klein, and N. Hogg. 2003. A novel form of integrin dysfunction involving beta1, beta2, and beta3 integrins. J. Clin. Invest. 111:51-60.
7. Felding-Habermann, B., T.E. O'Toole, J.W. Smith, E. Fransvea, Z.M. Ruggeri, M.H. Ginsberg, P.E. Hughes, N. Pampori, S.J. Shattil, A. Saven, and B.M. Mueller. 2001. Integrin activation controls metastasis in human breast cancer. Proc. Natl. Acad. Sci. USA. 98:1853-1858.
8. Czuchra, A., M. Hannelore, K.R. Legate, C. Brakebusch, and R. Fässler. 2006. Genetic analysis of β1 integrin "activation motifs" in mice. J. Cell Biol. 174:889-899.
9. Ginsberg, M.H., A. Partridge, and S.J. Shattil. 2005. Integrin regulation. Curr. Opin. Cell Biol. 17:509-516.
10. Quinn, M.J., T.V. Byzova, J. Qin, E.J. Topol, and E.F. Plow. 2003. Integrin alphaIIbbeta3 and its antagonism. Arterioscler. Thromb. Vasc. Biol. 23:945-952.
11. Offermanns, S. 2000. The role of heterotrimeric G proteins in platelet activation. Biol. Chem. 381:389-396.
12. Ratnikov, B.I., A.W. Partridge, and M.H. Ginsberg. 2005. Integrin activation by talin. J. Thromb. Haemost. 3:1783-1790.
13. Rees, D.J., S.E. Ades, S.J. Singer, and R.O. Hynes. 1990. Sequence and domain structure of talin. Nature. 347:685-689.
14. Monkley, S.J., C.A. Pritchard, and D.R. Critchley. 2001. Analysis of the mammalian talin2 gene TLN2. Biochem. Biophys. Res. Commun. 286:880-885.
15. Albiges-Rizo, C., P. Frachet, and M.R. Block. 1995. Down regulation of talin alters cell adhesion and the processing of the alpha 5 beta 1 integrin. J. Cell Sci. 108:3317-3329.
16. Critchley, D.R. 2000. Focal adhesions -the cytoskeletal connection. Curr. Opin. Cell Biol. 12:133-139.
17. Tadokoro, S., S.J. Shattil, K. Eto, V. Tai, R.C. Liddington, J. M. de Pereda, M.H. Ginsberg, and D.A. Calderwood. 2003. Talin binding to integrin beta tails: a final common step in integrin activation. Science. 302:103-106.
18. Petrich, B.G., P. Fogelstrand, A.W. Partridge, N. Yousefi, A.J. Ablooglu, S.J. Shattil, and M.H. Ginsberg. 2007. The antithrombotic potential of selective blockade of talin-dependent integrin alpha(IIb)beta(3) (platelet GPIIb-IIIa) activation. J. Clin. Invest. 117:2250-2259.
19. Monkley, S.J., X.H. Zhou, S.J. Kinston, S.M. Giblett, L. Hemmings, H. Priddle, J.E. Brown, C.A. Pritchard, D.R. Critchley, and R. Fassler. 2000. Disruption of the talin gene arrests mouse development at the gastrulation stage. Dev. Dyn. 219:560-574.
20. Kuhn, R., F. Schwenk, M. Aguet, and K. Rajewsky. 1995. Inducible gene targeting in mice. Science. 269:1427-1429.
21. Nieswandt, B., C. Brakebusch, W. Bergmeier, V. Schulte, D. Bouvard, R. Mokhtari-Nejad, T. Lindhout, J.W. Heemskerk, H. Zirngibl, and R. Fassler. 2001. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J. 20:2120-2130.
22. Masumoto, A., and M.E. Hemler. 1993. Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1. J. Biol. Chem. 268:228-234.
23. Yan, B., D.D. Hu, S.K. Knowles, and J.W. Smith. 2000. Probing chemical and conformational differences in the resting and active conformers of platelet integrin alpha(IIb)beta(3). J. Biol. Chem. 275:7249-7260.
24. Bergmeier, W., V. Schulte, G. Brockhoff, U. Bier, H. Zirngibl, and B. Nieswandt. 2002. Flow cytometric detection of activated mouse integrin alphaIIbbeta3 with a novel monoclonal antibody. Cytometry. 48:80-86.
25. Savage, B., F. Almus-Jacobs, and Z.M. Ruggeri. 1998. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 94:657-666.
26. McCarty, O.J., M.K. Larson, J.M. Auger, N. Kalia, B.T. Atkinson, A.C. Pearce, S. Ruf, R.B. Henderson, V.L. Tybulewicz, L.M. Machesky, and S.P. Watson. 2005. Rac1 is essential for platelet lamellipodia formation and aggregate stability under flow. J. Biol. Chem. 280:39474-39484.
27. Savage, B., S.J. Shattil, and Z.M. Ruggeri. 1992. Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J. Biol. Chem. 267:11300-11306.
28. Gruner, S., M. Prostredna, V. Schulte, T. Krieg, B. Eckes, C. Brakebusch, and B. Nieswandt. 2003. Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo. Blood. 102:4021-4027.
29. Chen, H., Z. Zou, K.L. Sarratt, D. Zhou, M. Zhang, E. Sebzda, D.A. Hammer, and M.L. Kahn. 2006. In vivo beta1 integrin function requires phosphorylation-independent regulation by cytoplasmic tyrosines. Genes Dev. 20:927-932.
30. Hodivala-Dilke, K.M., K.P. McHugh, D.A. Tsakiris, H. Rayburn, D. Crowley, M. Ullman-Cullere, F.P. Ross, B.S. Coller, S. Teitelbaum, and R.O. Hynes. 1999. Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Invest. 103:229-238.